Introduction
Leading healthcare and technology firms announced a collaboration to capture, collect and recycle waste anaesthetic gases, supporting environmental goals and sustainable anaesthesia supply globally worldwide.
Also Read: Allied Blenders arm makes luxury debut with ₹11 lakh 34-year-old ‘The Collective’ single malt
Share price movement of Piramal Pharma
On February 6, 2026, Piramal Pharma Ltd opened at ₹159.10, up 0.44% from its previous close of ₹158.40. The stock touched a high of ₹159.10 and a low of ₹154.70. By 11:11 AM, it traded at ₹157.15, down 0.79%, with a market capitalisation of ₹20,889.13 crore.
Piramal, Blue-Zone Partner on Anaesthetic Gas Recycling
Piramal Critical Care Inc, an overseas step – down wholly-owned subsidiary of Piramal Pharma Limited and Blue-Zone Technologies Ltd announced a collaboration to capture, collect and recycle waste anaesthetic gases using full lifecycle technology, aiming to reduce environmental impact.
Blue-Zone’s waste anaesthesia gas capture and processing technology will combine with Piramal’s global manufacturing and marketing capabilities to support healthcare customers in minimizing volatile anaesthetic emissions.
Subject to European regulatory approval, Blue-Zone will supply Phoenix Deltasorb systems in France and Germany, while Piramal will process captured gas to produce Sevoflurane USP in Canada.
Stock performance of Piramal Pharma for Period of 1 week, 6 months, and 1 year
Piramal Pharma Ltd delivered a 2.53% return over the past week, declined 16.6% over the past six months, and fell 31.0% over the past one year.
Also Read: Oberoi Realty emerges highest bidder with ₹5,400 Cr offer for prime Mumbai railway land
Shareholding pattern of Piramal Pharma
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 |
| Promoter | 34.90% | 34.90% | 34.90% |
| FII | 29.70% | 30.30% | 30.90% |
| DII | 15.70% | 14.90% | 14.30% |
| Public | 19.40% | 19.50% | 19.50% |
| Others | 1% | 0.50% | 0.60% |
About Piramal Pharma
Piramal Pharma Limited (NSE: PPLPHARMA) operates global pharma manufacturing, critical care, CDMO and consumer healthcare businesses, with presence across 100 countries and strategic investments.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
Q: Why is Piramal Pharma Ltd share price rising today?
A: Piramal Pharma Ltd share price is in focus following collaboration announcement by its subsidiary with Blue-Zone Technologies on anaesthetic gas recycling.
Q: What is Piramal Pharma Ltd’s main business focus?
A: Piramal Pharma Ltd focuses on pharmaceutical manufacturing, critical care generics, contract development services, and consumer healthcare products globally.
Q: What are the 52-week high and low of Piramal Pharma Ltd stock?
A: Piramal Pharma Ltd stock has a 52-week high of ₹241.00 and a 52-week low of ₹148.30 on exchanges.
